+1803294983432
customer.service@microbix.com
Respiratory Viral and Bacterial External Quality Controls
In vitro diagnostic (IVD) and research use only (RUO) bacterial and respiratory viral controls for nucleic acid and antigen detection assays.
Setting the Gold Standard for Infectious Disease Diagnostic Standards
Ready to Use External Quality Controls
Microbix is the only supplier licensed to manufacture respiratory viral control products on Copan’s FLOQSwabs®. These swabs are room-temperature stable with a wide storage range of 2–30°C.
Global Manufacturing Excellence
Manufactured under strict requirements of ISO 13485:2016, most of Microbix’s IVD quality controls are CE marked and registered with the U.S. FDA, Australian TGA, U.K., and Health Canada establishment-licensed.
Unique Diagnostics Solutions
Microbix offers inactivated multiplex SARS-CoV-2/FluA&B/RSV positive swabs that mimic patient specimen formats. Multiple levels of single-analyte SARS-CoV-2, RSV, Influenza A, and Influenza B swab products are also available.
Download Our Full Product Brochure
Bacterial and Respiratory Viral Molecular Controls Products
| Product Name | REDx™ (IVD) Catalogue Number |
PROCEEDx™ (RUO) Catalogue Number |
|
| Single Analyte Products | |||
| Adenovirus Positive | Coming soon | VP-15-01 | Request Quote |
| Parainfluenza 3 Virus Positive | Coming soon | VP-10-M1 | Request Quote |
| Influenza A Positive | RED-13-01* | VP-13-01 | Request Quote |
| Influenza A Positive Swab | RED-S-13-01 | VP-S-13-01 | Request Quote |
| Respiratory NAAT Influenza A Positive Swab | RED-S-13-M1* | VP-S-13-M1 | Request Quote |
| Respiratory NAAT Influenza A Positive Swab (Low Level) | RED-S-13-M1L* | VP-S-13-M1L | Request Quote |
| Influenza A NAAT Positive Swab (Ultra Low) | N/A | VP-S-13-L1 | Request Quote |
| Influenza B Positive | RED-14-01 | VP-14-01 | Request Quote |
| Influenza B Positive Swab | RED-S-14-01* | VP-S-14-01 | Request Quote |
| Respiratory NAAT Influenza B Positive Swab | RED-S-14-M1* | VP-S-14-M1 | Request Quote |
| Respiratory NAAT Influenza B Positive Swab (Low Level) | RED-S-14-M1L* | VP-S-14-M1L | Request Quote |
| Influenza B NAAT Positive Swab (Ultra Low) | N/A | VP-S-14-L1 | Request Quote |
| RSV Positive | RED-07-01* | VP-07-01 | Request Quote |
| RSV Positive Swab | RED-S-07-01* | VP-S-07-01 | Request Quote |
| Respiratory NAAT RSV Positive Swab | RED-S-07-M1* | VP-S-07-M1 | Request Quote |
| Respiratory NAAT RSV Positive Swab (Low level) | RED-S-07-M1L* | VP-S-07-M1L | Request Quote |
| Respiratory NAAT RSV Positive Swab (Ultra Low) | N/A | VP-S-07-L1 | Request Quote |
| Group A Strep Positive Swab (M1) | RED-S-70-M1* | VP-S-70-M1 | Request Quote |
| Group A Strep Positive Swab (M2) | RED-S-70-M2* | VP-S-70-M2 | Request Quote |
| Group A Strep Positive Swab | RED-S-70-01* | VP-S-70-01 | Request Quote |
| Multiple Analyte Products | |||
| Influenza A + Influenza B Positive | RED-13-02* | VP-13-02 | Request Quote |
| Respiratory NAAT Influenza A and Influenza B Positive Swab | RED-S-13-M2* | VP-S-13-M2 | Request Quote |
| Influenza A + RSV Positive | N/A | VP-13-03 | Request Quote |
| Respiratory NAAT Influenza A and RSV Positive Swab | RED-S-13-M3* | VP-S-13-M3 | Request Quote |
| Influenza A + Adenovirus Positive | N/A | VP-13-04 | Request Quote |
| Influenza A + Rotavirus Positive | N/A | VP-13-05 | Request Quote |
| Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab | RED-S-13-M4* | VP-S-13-M4 | Request Quote |
| Influenza B + RSV Positive | Coming soon | VP-14-02 | Request Quote |
| Respiratory NAAT Influenza B and RSV Positive Swab | RED-S-14-M2* | VP-S-14-M2 | Request Quote |
| Influenza B + Adenovirus Positive | N/A | VP-14-03 | Request Quote |
| Influenza B + Rotavirus Positive | N/A | VP-14-04 | Request Quote |
| Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab | RED-S-14-M3* | VP-S-14-M3 | Request Quote |
| Adenovirus + RSV Positive | N/A | VP-07-02 | Request Quote |
| RSV + Rotavirus Positive | N/A | VP-07-03 | Request Quote |
| Adenovirus + Rotavirus Positive | N/A | VP-15-02 | Request Quote |
| Respiratory NAAT RSV and SARS-CoV-2 Positive Swab | RED-S-07-M2* | VP-S-07-M2 | Request Quote |
| SARS-CoV-2/FluA&B/RSV Positive Swab | RED-S-19-M1 | VP-S-19-M1 | Request Quote |
| Negative Analyte Products | |||
| Respiratory Negative Swab (REDx™FLOQ®) Negative Swab (PROCEEDx™FLOQ®) |
RED-S-99-01 | VP-S-99-01 | Request Quote |
| Negative Sample | Coming soon | VP-99-01 | Request Quote |
| SARS-CoV-2 Negative Swab (REDx™FLOQ®) NAAT Negative Swab (PROCEEDx™FLOQ®) |
RED-S-99-M4 | VP-S-99-M4 | Request Quote |
| Negative Sample (MDx) | Coming soon | VP-99-M2 | Request Quote |
SARS Complete Panel
| Product Name | REDx™ (IVD) Catalogue Number |
PROCEEDx™ (RUO) Catalogue Number |
|
| Single Analyte Products | |||
| SARS-CoV-2 Positive | RED-19-01 | VP-19-01 | Request Quote |
| SARS-CoV-2 Positive Swab | RED-S-19-01 | VP-S-19-01 | Request Quote |
| Respiratory NAAT SARS-CoV-2 Positive Swab (Ultra Low) | N/A | VP-S-19-L1 | Request Quote |
| SARS-CoV-2 Ag Positive Swab | RED-S-19-02 | VP-S-19-02 | Request Quote |
| SARS-CoV-2 B.1.1.7 Positive Swab | RED-S-19-03 | VP-S-19-03 | Request Quote |
| SARS-CoV-2 B.1.351 Positive Swab | RED-S-19-04 | VP-S-19-04 | Request Quote |
| SARS-CoV-2 P.1 Positive Swab | RED-S-19-05 | VP-S-19-05 | Request Quote |
| SARS-CoV-2 B.1.617 Positive Swab | RED-S-19-06 | VP-S-19-06 | Request Quote |
| SARS-CoV-2 B.1.1.529 Positive Swab | RED-S-19-07 | VP-S-19-07 | Request Quote |
| Multi-Analyte products | |||
| SARS-CoV-2/Flu A/ Flu B/ RSV Positive Swab | RED-S-19-M1 | VP-S-19-M1 | Request Quote |
| Respiratory NAAT Influenza A and SARS-CoV-2 Positive Swab | RED-S-13-M4* | VP-S-13-M4 | Request Quote |
| Respiratory NAAT Influenza B and SARS-CoV-2 Positive Swab | RED-S-14-M3* | VP-S-14-M3 | Request Quote |
| Respiratory NAAT RSV and SARS-CoV-2 Positive Swab | RED-S-07-M2* | VP-S-07-M2 | Request Quote |
| Negative Analyte Products | |||
| SARS-CoV-2 Negative | RED-99-M3 | VP-99-M3 | Request Quote |
| SARS-CoV-2 Negative Swab (REDx™FLOQ®) NAAT Negative Swab (PROCEEDx™FLOQ®) |
RED-S-99-M4 | VP-S-99-M4 | Request Quote |
| Respiratory Negative Swab (REDx™FLOQ®) Negative Swab (PROCEEDx™FLOQ®) |
RED-S-99-01 | VP-S-99-01 | Request Quote |
Frequently Asked Questions
What pathogens are included in your viral and bacterial panel?
The respiratory viral and bacterial panel controls include an extensive SARS-CoV-2 portfolio for nucleic acid and antigen detection assays, covering major concern variants (B.1.1.7, B.1.351, P.1, B.1.617, B.1.1.529). Other respiratory viral control products available as single-analyte or multiplex formats include:
- Influenza A, Influenza B, Respiratory Syncytial Virus (low, medium, and high levels)
- Group A Strep (low, medium, and high levels)
- Adenovirus, Parainfluenza Viruses, and additional common respiratory viruses
Are respiratory viral panel controls suitable for use by a clinical diagnostics laboratory?
Yes. Microbix offers two distinct product lines to meet different needs. Our REDx™ IVD products are unassayed respiratory viral control products that support ongoing QC, benchmarking of laboratory testing performance, operator training, and complete workflow evaluation. Our PROCEEDx™ RUO products are used for assay validation, verification, R&D applications, and training.
Are respiratory viral antigen controls compatible with commonly used diagnostic methods like PCR or rapid tests?
Yes. All Microbix QAPs™ respiratory viral control products are designed to be commutable, meaning they work with both molecular assays, such as PCR and immunoassay-based rapid tests. Compatibility is aligned with market needs, so products are validated for use in the most widely adopted diagnostic methods.
What is the shelf life of your respiratory viral antigen controls?
The shelf life of Microbix’s respiratory viral panel controls is up to 2 years from the manufacturing date when swabs are stored at 2–30°C, and 1 year from the manufacturing date when liquids are stored at 2–8°C.
Do you have a more concentrated version of the respiratory quality controls product line?
Microbix’s QUANTDx™ reference materials product line is formulated with highly concentrated, quantified, and traceable pathogens for a wide range of disease panels (fungal, respiratory, STI, and more).
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Trusted Source of Respiratory Viral and Bacterial External Quality Controls
Microbix’s easy-to-use swab and liquid formats make our respiratory viral control products a reliable choice for researchers, diagnostic manufacturers, and healthcare professionals.
The respiratory viral and bacterial panel controls include an extensive SARS-CoV-2 portfolio for nucleic acid and antigen detection assays, covering major concern variants (B.1.1.7, B.1.351, P.1, B.1.617, B.1.1.529). Other single-analyte and multiplex respiratory viral molecular controls include:
- Influenza A, Influenza B, Respiratory Syncytial Virus (low, medium, and high levels)
- Group A Strep (low, medium, and high levels)
- Adenovirus, Parainfluenza Viruses, and other common respiratory viruses
Speak to a Customer Service Representative
Let our knowledgeable experts help you secure your products today.
News & Insights from Our Diagnostics Experts
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the clinical use of the Allplex™ and Anyplex™ molecular multiplex assays of Seegene Mexico for detect...
Microbix Partners with SEKISUI Diagnostics to Support COVID/Flu Tests
announce that Microbix external third-party quality assessment products (REDx™FLOQ® QAPs®) will be used to support SEKISUI’s U.S. commercialization of the molecular point-of-care assay for diagnosis of CO...
Microbix Presenting at Muskoka Capital Event
Microbix announces that it will be presenting to investors at the Muskoka Capital Event, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Rosseau Muskoka, in Minett, Ontario, Septe...
